Medical Properties Trust Files Q2 2024 10-Q

TL;DR

**MPW Q2 10-Q filed. Financials and operations detailed.**

AI Summary

Medical Properties Trust, Inc. (MPW) filed its 10-Q for the period ending June 30, 2024. The filing details the company's financial performance and operational status. Key financial data and disclosures relevant to investors are presented in this report.

Why It Matters

This 10-Q filing provides investors with the latest financial and operational details for Medical Properties Trust, Inc., crucial for understanding the company's current health and future prospects.

Risk Assessment

Risk Level: medium — As a real estate investment trust, MPW is subject to market fluctuations and tenant-specific risks, which are detailed in their SEC filings.

Key Numbers

• Q2 2024 — Reporting Period (Covers the second quarter of 2024.)
• 1231 — Fiscal Year End (Indicates the company's fiscal year concludes on December 31st.)

Key Players & Entities

• Medical Properties Trust, Inc. (company) — Filer of the 10-Q
• MPT Operating Partnership, L.P. (company) — Related entity filing
• 20240630 (date) — End of reporting period
• 205-969-3755 (phone_number) — Business phone number

FAQ

Key Financial Figures

• $0.001 — ch registered Common stock, par value $0.001 per share, of Medical Properties Trust,
• $0 — llion shares of common stock, par value $0.001, outstanding. EXPLANATORY NOTE

Filing Documents

• mpw-20240630.htm (10-Q) — 3446KB
• mpw-ex10_1.htm (EX-10.1) — 1439KB
• mpw-ex31_1.htm (EX-31.1) — 13KB
• mpw-ex31_2.htm (EX-31.2) — 12KB
• mpw-ex31_3.htm (EX-31.3) — 12KB
• mpw-ex31_4.htm (EX-31.4) — 12KB
• mpw-ex32_1.htm (EX-32.1) — 10KB
• mpw-ex32_2.htm (EX-32.2) — 10KB
• 0000950170-24-094888.txt ( ) — 14353KB
• mpw-20240630.xsd (EX-101.SCH) — 1980KB
• mpw-20240630_htm.xml (XML) — 2121KB

— FINANCIAL INFORMATION

PART I — FINANCIAL INFORMATION 3

Financial Statements

Item 1 Financial Statements 3 Medical Properties Trust, Inc. and Subsidiaries Condensed Consolidated Balance Sheets at June 30, 2024 and December 31, 2023 3 Condensed Consolidated Statements of Net Income for the Three and Six Months Ended June 30, 2024 and 2023 4 Condensed Consolidated Statements of Comprehensive (Loss) Income for the Three and Six Months Ended June 30, 2024 and 2023 5 Condensed Consolidated Statements of Equity for the Three and Six Months Ended June 30, 2024 and 2023 6 Condensed Consolidated Statements of Cash Flows for the Six Months Ended June 30, 2024 and 2023 7 MPT Operating Partnership, L.P. and Subsidiaries Condensed Consolidated Balance Sheets at June 30, 2024 and December 31, 2023 8 Condensed Consolidated Statements of Net Income for the Three and Six Months Ended June 30, 2024 and 2023 9 Condensed Consolidated Statements of Comprehensive (Loss) Income for the Three and Six Months Ended June 30, 2024 and 2023 10 Condensed Consolidated Statements of Capital for the Three and Six Months Ended June 30, 2024 and 2023 11 Condensed Consolidated Statements of Cash Flows for the Six Months Ended June 30, 2024 and 2023 12 Medical Properties Trust, Inc. and MPT Operating Partnership, L.P. and Subsidiaries Notes to Condensed Consolidated Financial Statements 13

Management's Discussion and Analysis of Financial Condition and Results of Operations

Item 2 Management's Discussion and Analysis of Financial Condition and Results of Operations 31

Quantitative and Qualitative Disclosures about Market Risk

Item 3 Quantitative and Qualitative Disclosures about Market Risk 46

Controls and Procedures

Item 4 Controls and Procedures 47

— OTHER INFORMATION

PART II — OTHER INFORMATION 48

Legal Proceedings

Item 1 Legal Proceedings 48

A Risk Factors

Item 1 A Risk Factors 48

Unregistered Sales of Equity Securities and Use of Proceeds

Item 2 Unregistered Sales of Equity Securities and Use of Proceeds 48

Defaults Upon Senior Securities

Item 3 Defaults Upon Senior Securities 48

Mine Safety Disclosures

Item 4 Mine Safety Disclosures 48

Other Information

Item 5 Other Information 48

Exhibits

Item 6 Exhibits 49 SIGNATURE 50 2

— FINANC IAL INFORMATION

PART I — FINANC IAL INFORMATION

Finan cial Statements

Item 1. Finan cial Statements. MEDICAL PROPERTIES TRU ST, INC. AND SUBSIDIARIES Condensed Consolida ted Balance Sheets June 30, 2024 December 31, 2023 (In thousands, except per share amounts) (Unaudited) (Note 2) Assets Real estate assets Land, buildings and improvements, intangible lease assets, and other $ 11,949,385 $ 13,237,187 Investment in financing leases 1,181,959 1,231,630 Mortgage loans 399,150 309,315 Gross investment in real estate assets 13,530,494 14,778,132 Accumulated depreciation and amortization ( 1,417,910 ) ( 1,407,971 ) Net investment in real estate assets 12,112,584 13,370,161 Cash and cash equivalents 606,550 250,016 Interest and rent receivables 39,471 45,059 Straight-line rent receivables 664,271 635,987 Investments in unconsolidated real estate joint ventures 1,143,231 1,474,455 Investments in unconsolidated operating entities 635,206 1,778,640 Other loans 505,942 292,615 Other assets 487,488 457,911 Total Assets $ 16,194,743 $ 18,304,844 Liabilities and Equity Liabilities Debt, net $ 9,369,064 $ 10,064,236 Accounts payable and accrued expenses 446,893 412,178 Deferred revenue 25,700 37,962 Obligations to tenants and other lease liabilities 160,009 156,603 Total Liabilities 10,001,666 10,670,979 Equity Preferred stock, $ 0.001 par value. Authorized 10,000 shares; no shares outstanding — — Common stock, $ 0.001 par value. Authorized 750,000 shares; issued and outstanding — 600,057 shares at June 30, 2024 and 598,991 shares at December 31, 2023 600 599 Additional paid-in capital 8,571,662 8,560,309 Retained deficit ( 2,348,170 ) ( 971,809 ) Accumulated other comprehensive (loss) income ( 33,910 ) 42,501 Total Medical Properties Trust, Inc. stockholders' equity 6,190,182 7,631,600 Non-controlling interests 2,895 2,265 Total Equity 6,193,077

View Full Filing

View this 10-Q filing on SEC EDGAR